Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new Revision: v3.3.3 entry was added to the record history, while the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. These are minor metadata updates to the history page and footer text. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRecord History shows a new revision entry (v3.3.2) added and an older revision (v3.2.0) removed. This is a backend version-tracking update and does not modify study data or visible content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe notice about government funding operating status has been removed from the page, while the core trial record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check67 days agoChange DetectedOnly minor UI/layout changes and a new entry appear in the Record History. There are no changes to core study data such as enrollment, status, or outcomes; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference12%

- Check103 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.